Filter
1998
Filtered Results: 1998
Text search:
vector
Featured
Recommendations
173
New Publications
607
Language
Document type
No document type
968
Studies & Reports
431
Guidelines
264
Strategic & Response Plan
98
Manuals
96
Fact sheets
58
Training Material
30
Situation Updates
20
Infographics
15
Resource Platforms
12
Brochures
2
Videos
2
Dashboards/Maps
1
Online Courses
1
Countries / Regions
Global
120
Latin America and the Carribbean
73
India
58
Kenya
38
Africa
37
Ethiopia
35
Uganda
35
Sierra Leone
31
Liberia
31
Venezuela
30
Brazil
28
Mozambique
27
Senegal
25
Paraguay
25
Colombia
24
Congo, Democratic Republic of
23
Nepal
22
Nigeria
21
Argentina
20
Western and Central Europe
20
Myanmar / Burma
19
Malawi
18
Bangladesh
17
Ghana
16
Zambia
16
Tanzania
15
Rwanda
15
South Africa
15
South Sudan
14
East and Southern Africa
14
South–East Asia Region
14
West and Central Africa
13
Guinea
12
Zimbabwe
12
Philippines
12
Madagascar
12
Burkina Faso
11
Indonesia
11
Namibia
11
Bolivia
11
Germany
9
Peru
9
Middle East and North Africa
9
Syria
8
Ukraine
8
Cameroon
7
Haiti
7
Benin
7
Asia
7
Russia
7
Chad
6
Sudan
6
Botswana
6
USA
5
Somalia
5
Angola
5
Chile
5
Mali
4
Pakistan
4
Lebanon
4
Cambodia
4
Central African Republic
4
Ecuador
4
El Salvador
4
Yemen
4
Eastern Europe and Central Asia
4
Guinea-Bissau
3
Jordan
3
Papua New Guinea
3
Eswatini/ Swaziland
3
Honduras
3
Western Pacific Region
3
Eastern Europe
3
Albania
3
Laos
3
Spain
3
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Togo
2
Iraq
2
Turkey
2
Thailand
2
China
2
Dominican Republic
2
Lesotho
2
Mexico
2
Palestine
2
Iran
2
Vietnam
2
North America
2
United Kingdom
2
Morocco
1
Niger
1
Afghanistan
1
Egypt
1
Gambia
1
Mauritania
1
Singapore
1
Vanuatu
1
North Macedonia
1
Burundi
1
Greece
1
Libya
1
Guatemala
1
Other region
1
Italy
1
Djibouti
1
Southern Africa
1
Timor Leste/ East Timor
1
Tajikistan
1
Qatar
1
Georgia
1
Uruguay
1
Japan
1
France
1
Mauritius
1
Tunisia
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
731
Clinical Guidelines
172
Public Health
148
Key Resources
116
Women & Child Health
36
Capacity Building
25
Pharmacy & Technologies
23
Toolboxes
NTDs
224
Planetary Health
220
Rapid Response
182
COVID-19
174
Zika
144
Natural Hazards
65
Global Health Education
63
Ebola
55
AMR
34
Conflict
30
HIV
29
TB
23
Refugee
21
Caregiver
21
Health Financing Toolbox
19
Mental Health
18
Pharmacy
15
Cholera
12
Specific Hazards
9
Disability
8
NCDs
6
Typhoon
4
Polio
1
Health Financing
1
PLoS Negl Trop Dis 10(3): e0004530 -Published: March 2, 2016
This paper reviews the status of the Zika virus outbreak, including medical countermeasureoptions, with a focus on how the epidemiology, insect vectors, neuropathology, virology and immun...
Zika and dengue viruses remain significant public health threats. These viruses share the same Aedes (Stegomyia) mosquito vectors and geographic distributions but infections cannot be readily distinguished clinically and need to be differentiated fr...
PAHO has systematically identified and collected basic information on all investigations related to Zika, both those already published and those on track to be published.
Each study has been categorized in the areas of virus, vectors and reservoir...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an...
Chagas disease is named after the Brazilian physician Carlos Chagas, who discovered the disease in 1909. It is caused by the parasite Trypanosoma cruzi, which is transmitted to animals and people by insect vectors and is found only in the Americas (...
Chagas disease (American trypanosomiasis) is endemic in 21 countries of the Americas, where control is largely focused on elimination of the domestic insect vectors (Triatominae) coupled with measures to extend and improve the screening of blood don...
The present book deals not only with emergency response, but also with measures designed to reduce the impact of disasters on environmental health infrastructure, such as water supply and sanitation facilities. It also aims to strengthen the ability of people to withstand the disruption of their acc...
Dengue is a mosquito-borne viral disease that has rapidly spread to all regions of WHO in recent years. Dengue virus is transmitted by female mosquitoes mainly of the species Aedes aegypti and, to a lesser extent, Ae. albopictus. These mosquitoes are also ...s of chikungunya, yellow fever and Zika viruses. Dengue is widespread throughout the tropics, with local variations in risk influenced by climate parameters as well as social and environmental factors.
WASH Training for Hygiene Promotion Staff.
This manual has been designed to train NRC hygiene promotion incentive staff on ... concept and importance of hygiene, diseases that are present or a risk in Kakuma Refugee. Camp and how to prevent them; monitoring WASH activities and prevention, managemen...
167,607 dengue cases, including 720 deaths, reported from 1 January to 27 July 2019: 97% higher than in 2018, in spite of a delayed rainy season.
Case Fatality Rate (CFR) of 0.43% as of 27 July 2019 is lower than in the same time period in 2018 (0.54%), but still significantly higher than the reg...
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral ... vaccine against coronavirus disease 2019 (COVID-19). The vaccine expresses the SARS-CoV-2 spike protein gene, which instructs the host cells to produce the protein of the S-antigen unique to SARS-CoV-2, allowing the body to generate an immune response and to retain that information in memory immune cells. Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) irrespective of interval between the doses was 63.1%, based on a median follow-up of 80 days, but tended to be higher when this interval was longer. The data reviewed at this time support the conclusion that the known and potential benefits of ChAdOx1-S/nCoV-19 [recombinant] vaccine outweigh the known and potential risks.
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti...
Climate change is a verified, global phenomenon, but its consequences will not be evenly distributed. Developing countries and small island nations will be the most affected. Countries will experience more frequent extreme weather events and resulting changes in water quality and availability, incre...
This open access book not only describes the challenges of climate disruption, but also presents solutions. The challenges described include air pollution, climate change, extreme weather, and related health impacts that range from heat stress, vector...
Int. J. Environ. Res. Public Health 2021, 18(24), 13339; https://doi.org/10.3390/ijerph182413339
The climate crisis threatens to exacerbate numerous climate-sensitive health risks, including heatwave mortality, malnutrition from reduced crop yields, water- and ...-borne infectious diseases, and respiratory illness from smog, ozone, allergenic pollen, and wildfires. Recent reports from the Intergovernmental Panel on Climate Change stress the urgent need for action to mitigate climate change, underscoring the need for more scientific assessment of the benefits of climate action for health and wellbeing.
Pakistan Crisis 2022
recommended
WHO is responding as Pakistan is affected by massive monsoon rainfall and unprecedented levels of flooding and landslides. Damage to health infrastructure, shortages of health workers, and limited health supplies are disrupting health services. Significant public health threats include the spread of...
Carlos Chagas discovered American trypanosomiasis, also named Chagas disease (CD) in his honor, just over a century ago. He described the clinical aspects of the disease, characterized by its etiological agent (Trypanosoma cruzi) and identified its insect .... Initially, CD occurred only in Latin America and was considered a silent and poorly visible disease. More recently, CD became a neglected worldwide disease with a high morbimortality rate and substantial social impact, emerging as a significant public health threat. In this context, it is crucial to better understand better the epidemiological scenarios of CD and its transmission dynamics, involving people infected and at risk of infection, diversity of the parasite, vector species, and T. cruzi reservoirs. Although efforts have been made by endemic and non-endemic countries to control, treat, and interrupt disease transmission, the cure or complete eradication of CD are still topics of great concern and require global attention. Considering the current scenario of CD, also affecting non-endemic places such as Canada, USA, Europe, Australia, and Japan, in this review we aim to describe the spread of CD cases worldwide since its discovery until it has become a global public health concern.
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
Discrete typing units of Trypanosoma cruzi: Geographical and biological distribution in the Americas
Chagas disease caused by Trypanosoma cruzi is a public health issue in Latin America. This highly diverse parasite is divided into at least seven discrete typing units (DTUs) TcI-TcVI and Tcbat. Some DTUs have been associated with geographical distribution in epidemiological scenarios and clinical m...
Chagas disease, also known as American trypanosomiasis, is a potentially life-threatening illness caused by the protozoan parasite Trypanosoma cruzi. About 6–7 million people worldwide are estimated to be infected with T. cruzi. The disease is found mainly in endemic areas of 21 continental Lati...
